A Calatroni, R Vinci, A M Ferlazzo
Index: Clin. Chim. Acta 206 , 167-180, (1992)
Full Text: HTML
Acid glycosaminoglycans were isolated from normal human plasma: (a) following fractionation of plasma (with protease inhibitors) on Sephadex G-200; (b) by ultrafiltration through membranes with retention of molecules above 50 kDa, with and without previous addition of NaCl, Triton X-100, urea, or guanidine HCl; (c) by filtering on Ecteola-cellulose either untreated plasma or after treatment with NaCl, urea, Triton X-100, papain or NaOH. More than 95% of plasma glycosaminoglycans interact with plasma proteins to give complexes that exhibit reproducible behaviour on Sephadex G-200 and are retained by ultrafiltration membranes, which the 12-20 kDa polysaccharide chains do filter. High charge plasma glycosaminoglycans show ionic interactions with proteins, while low charge glycosaminoglycan interactions are resistant to Ecteola charged groups, to 0.5% Triton and 4 M urea, while not to 4 M guanidine HC1. Some glycosaminoglycan-protein complexes appear resistant to proteolysis, suggesting that they may originate from lymphocytes. The simple method utilized for plasma GAG measurement may represent an useful tool in clinical practice.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Spermine
CAS:9015-13-8 |
C10H26N4 |
Optimized Treatment of Heparinized Blood Fractions to Make T...
2015-08-01 [Biopreserv. Biobank. 13 , 287-95, (2015)] |
A modified thromboelastographic method for monitoring c7E3 F...
1997-01-01 [Anesth. Analg. 84 , 31-38, (1997)] |
Improved high-performance liquid chromatographic method to e...
2001-12-25 [J. Chromatogr. B. Biomed. Sci. Appl. 765 , 151-160, (2001)] |
Monitoring heparin therapy: relationships between the activa...
1990-02-19 [Thromb. Haemost. 63(1) , 16-23, (1990)] |
Enzymatic elimination of heparin from plasma for activated p...
1993-08-01 [Blood Coagul. Fibrinolysis 4(4) , 635-8, (1993)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved